(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
What we know about the Brown University shooting suspect who was found dead, and how police linked him to the MIT killing - 2James Webb Space telescope spots 'big red dot' in the ancient universe: A ravenous supermassive black hole named 'BiRD'
- 3If someone's always late, is it time blindness, or are they just being rude?
- 4Twins were the norm for our ancient primate ancestors − one baby at a time had evolutionary advantages
- 5Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- Dental Embed Innovation: An Achievement in Helpful Dentistry
- EPA watchdog finds nation’s most contaminated sites are vulnerable to flooding, wildfires
- Watch Chinese astronauts enjoy '1st ever space BBQ' from Tiangong's brand-new oven (video)
- She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot.
- Computerized Moderation: Tracking down Equilibrium in the Advanced Age
- 'The Housemaid' movie with Sydney Sweeney and Amanda Seyfried premieres this month. What the stars have said about the psychological thriller.
- Which Breakfast Enraptures Your Taste Buds? Vote
- Remarkable Spots for Hot Air Swelling All over The Planet
- Manual for Vegetarian Protein Powder
